Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial

- Forbes, John F., Sestak, Ivana, Holcombe, Chris, Coleman, Robert E., Jones, Louise, Ellis, Ian, Cuzick, Jack, Howell, Anthony, Bonanni, Bernardo, Bundred, Nigel, Levy, Christelle, von Minckwitz, Gunter, Eiermann, Wolfgang, Neven, Patrick, Stierer, Michael

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

- Cuzick, Jack, Sestak, Ivana, Bonanni, Bernardo, Palva, Tina, Howell, Anthony, Forbes, John F., Dowsett, Mitch, Knox, Jill, Cawthorn, Simon, Saunders, Christobel, Roche, Nicola, Mansel, Robert E., von Minckwitz, Gunter